The Autism Therapy Market is expected to register a CAGR of 7.8% from 2025 to 2031, with a market size expanding from US$ XX Million in 2024 to US$ XX Million by 2031.
The research report on the Autism Therapy Market is segmented by type into behavioral therapies, speech therapies, occupational therapies, and pharmacological treatments. Applications analyzed include autism spectrum disorder (ASD) management, early intervention programs, and therapy for social communication issues. End-users include therapy centers, hospitals, pharmaceutical companies, and specialized clinics. The regional analysis covers key markets such as North America, Europe, Asia Pacific, the Middle East and Africa, and South America. The market evaluation is presented in US$ for all segmental analyses. This report focuses on the growing demand for early autism therapies, innovative treatment options, and the rise of specialized programs for children with ASD.
Purpose of the ReportThe report Autism Therapy Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Autism Therapy Market Segmentation
Therapy- Communication and Behavioural Therapies
- Drug Therapies
- Asperger's Syndrome
- Autistic Disorder
- Childhood Disintegrative Disorder
- Pervasive Developmental Disorder
Strategic Insights
Autism Therapy Market Growth Drivers- Increasing Prevalence of Autism Spectrum Disorder (ASD):
Autism Spectrum Disorder (ASD) is a neurodevelopmental condition that affects millions of individuals worldwide. The growing recognition of ASD, along with improvements in diagnostic tools and greater awareness of its symptoms, is contributing to a rising prevalence of autism diagnoses. It is estimated that approximately 1 in 44 children in the U.S. is diagnosed with autism, according to the CDC. As the number of individuals diagnosed with ASD continues to rise, the demand for autism therapies is expected to grow. This includes both early intervention therapies, which focus on younger children, and therapies for adolescents and adults with autism. Early and effective therapy plays a crucial role in improving social, communication, and behavioral skills in individuals with ASD, fueling the demand for treatment options. As the prevalence of autism increases globally, the market for therapies, including behavioral therapies, speech therapy, and medication, is expanding.
- Advancements in Behavioral and Educational Therapies:
Behavioral therapies, particularly Applied Behavior Analysis (ABA), are considered the gold standard in autism treatment. These therapies focus on reinforcing positive behaviors and teaching new skills, helping individuals with autism improve their social and communication abilities. The growing body of evidence supporting the effectiveness of ABA therapy is driving its adoption worldwide. In addition to ABA, other behavioral and educational therapies like speech therapy, occupational therapy, and social skills training are also gaining traction. The focus on early intervention through behavioral therapies helps improve long-term outcomes for individuals with autism, leading to increased investment in research and development of new treatment methodologies. As healthcare professionals and educators develop better and more individualized treatment plans, the demand for autism therapies is expected to grow.
- Increased Government Support and Awareness:
Government support and public awareness initiatives have played a significant role in driving the growth of the autism therapy market. Various governments have implemented policies and funding programs to promote early autism diagnosis and treatment. In the U.S., the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) have been involved in increasing awareness about autism and funding research into therapies. Similar initiatives are being implemented in Europe and other regions, with governments encouraging schools, healthcare providers, and therapists to adopt evidence-based interventions. Public awareness campaigns are also helping reduce the stigma around autism, making it more acceptable for individuals to seek treatment. As awareness grows, so does the demand for appropriate therapies, which drives market growth.
- Growing Demand for Telehealth and Digital Therapy Solutions: The COVID-19 pandemic accelerated the adoption of telehealth, including remote autism therapy sessions, which have continued to gain popularity due to convenience and accessibility. Digital therapy platforms, mobile applications, and online counseling services are increasingly used to provide therapeutic services to individuals with autism. These platforms often include video-based therapy, skill-building modules, and interactive tools that allow patients and families to engage in therapy from the comfort of their homes. For example, virtual ABA therapy has shown promise in helping children with autism develop important skills such as communication, social interaction, and self-regulation. As telehealth platforms continue to improve, the autism therapy market is likely to see greater integration of technology into treatment plans, expanding access to therapies for individuals in remote or underserved regions. This trend will not only improve convenience but also allow for real-time monitoring of progress, enhancing the quality of care.
- Rise of Early Intervention Programs:
Early intervention is crucial in helping children with autism develop the necessary skills for better functioning throughout their lives. Research has shown that intensive, early intervention programs that include therapies such as ABA can significantly improve developmental outcomes, particularly when implemented before the age of 5. As a result, there is a growing trend toward offering early autism diagnosis and intervention services. Schools, clinics, and therapy centers are increasingly focusing on early-stage therapies to provide children with autism the best possible start. Additionally, the increasing availability of state-funded programs and insurance reimbursement for early autism intervention has made these therapies more accessible to families. With the emphasis on early intervention gaining traction, the demand for autism therapies is expected to continue to rise, particularly in pediatric settings.
- Personalized and Holistic Approaches to Autism Therapy:
There is a growing shift toward personalized, patient-centered therapies for autism, reflecting a move away from one-size-fits-all treatment approaches. Personalized therapy plans are developed based on the individual’s specific needs, strengths, and challenges, integrating behavioral, speech, and occupational therapies. For instance, a tailored ABA therapy program may incorporate a child's unique communication preferences or sensory sensitivities. Additionally, more holistic approaches are gaining attention, combining traditional therapies with complementary treatments such as art therapy, music therapy, and animal-assisted therapy. These approaches focus on improving the child’s emotional well-being and social skills. The trend toward individualized, holistic care for autism is expected to improve treatment outcomes and satisfaction for both patients and their families, and it reflects a broader shift in healthcare toward patient-specific solutions.
- Growth of Autism Treatment Centers and Specialized Schools: The establishment of specialized autism treatment centers and schools dedicated to serving individuals with ASD is an area of significant growth. These centers and schools focus on providing individualized education and therapy, including ABA, speech therapy, and social skills training. As awareness of autism grows and more families seek specialized care, there is an increasing demand for facilities that can provide comprehensive treatment options. These centers not only offer therapy but also foster social development and skills training in a safe, controlled environment. By expanding these specialized treatment options, the autism therapy market is poised to capture a larger share of the growing demand for autism services. Additionally, as funding for such centers increases and more governments recognize the importance of specialized autism services, this market segment is likely to see further growth.
- Pharmaceutical and Drug-Based Therapies: While behavioral and educational therapies are the cornerstone of autism treatment, there is increasing interest in the development of pharmaceutical therapies to address some of the co-occurring conditions associated with autism, such as anxiety, hyperactivity, and irritability. Several medications are currently being tested in clinical trials to manage symptoms of autism, including selective serotonin reuptake inhibitors (SSRIs), antipsychotics, and stimulants. Recent research into neurodevelopmental drugs aimed at improving cognitive and social function in individuals with autism also presents opportunities for pharmaceutical companies. The growing focus on drug-based therapies that can complement existing interventions opens a new avenue in autism treatment, potentially leading to the development of more effective symptom management strategies. As such therapies gain regulatory approval, the pharmaceutical sector will play an increasingly important role in the autism therapy market.
- Increased Focus on Autism Research and Innovation: The growing recognition of autism as a complex neurodevelopmental disorder has led to an increase in research funding and innovation in autism therapies. Researchers are exploring new ways to treat autism, including exploring the role of the microbiome in autism, genetic therapies, and the potential use of advanced technologies like virtual reality for social skills training. Additionally, there is growing interest in understanding the neurobiological mechanisms underlying ASD, which could lead to novel therapeutic targets. The expansion of research efforts, including clinical trials and studies on new therapies, presents significant opportunities for pharmaceutical and biotech companies in the autism therapy space. The commercialization of new therapies and the integration of innovative approaches into treatment plans offer the potential to significantly improve the quality of life for individuals with autism, providing lucrative opportunities for stakeholders in the autism therapy market.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Autism Therapy Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Autism Therapy Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?

Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
This text is related
to segments covered.

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Autism Therapy Market is expected to register a CAGR of 7.8% from 2025-2031.
The major driving factors supporting the Autism Therapy Market growth are- Increasing Prevalence of Autism Spectrum Disorder (ASD), Advancements in Behavioral and Educational Therapies
Key Future Trends in the Autism Therapy Market are- Growing Demand for Telehealth and Digital Therapy Solutions, Rise of Early Intervention Programs, and Personalized and Holistic Approaches to Autism Therapy
Key companies in Autism Therapy Market are - AbbVieInc (Allergan) , PfizerInc , JohnsonandJohnsonServicesInc , AstraZenecaPlc , QBioMedInc , AutismSpeaksInc , TrumpetBehavioralHealth , FusionAutismCenter , HopebridgeAutismTherapyCenter
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Autism Therapy Market - By Therapy
1.3.2 Autism Therapy Market - By Type
1.3.3 Autism Therapy Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. AUTISM THERAPY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. AUTISM THERAPY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. AUTISM THERAPY MARKET - GLOBAL MARKET ANALYSIS
6.1. AUTISM THERAPY - GLOBAL MARKET OVERVIEW
6.2. AUTISM THERAPY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. AUTISM THERAPY MARKET - REVENUE AND FORECASTS TO 2028 - THERAPY
7.1. OVERVIEW
7.2. THERAPY MARKET FORECASTS AND ANALYSIS
7.3. COMMUNICATION AND BEHAVIORAL THERAPIES
7.3.1. Overview
7.3.2. Communication and Behavioural Therapies Market Forecast and Analysis
7.3.3. Occupational Therapy Market
7.3.3.1. Overview
7.3.3.2. Occupational Therapy Market Forecast and Analysis
7.3.4. Speech Therapy Market
7.3.4.1. Overview
7.3.4.2. Speech Therapy Market Forecast and Analysis
7.3.5. Applied Behaviour Analysis (ABA) Market
7.3.5.1. Overview
7.3.5.2. Applied Behaviour Analysis (ABA) Market Forecast and Analysis
7.3.6. Social Skills Market
7.3.6.1. Overview
7.3.6.2. Social Skills Market Forecast and Analysis
7.3.7. Therapeutic Horseback Riding Market
7.3.7.1. Overview
7.3.7.2. Therapeutic Horseback Riding Market Forecast and Analysis
7.3.8. Picture Exchange Communication System (PECS) Market
7.3.8.1. Overview
7.3.8.2. Picture Exchange Communication System (PECS) Market Forecast and Analysis
7.4. DRUG THERAPIES
7.4.1. Overview
7.4.2. Drug Therapies Market Forecast and Analysis
7.4.3. Antipsychotic Drugs Market
7.4.3.1. Overview
7.4.3.2. Antipsychotic Drugs Market Forecast and Analysis
7.4.4. Selective Serotonin Reuptake Inhibitors (SSRIS) Market
7.4.4.1. Overview
7.4.4.2. Selective Serotonin Reuptake Inhibitors (SSRIS) Market Forecast and Analysis
7.4.5. Stimulants Market
7.4.5.1. Overview
7.4.5.2. Stimulants Market Forecast and Analysis
7.4.6. Sleep Medications Market
7.4.6.1. Overview
7.4.6.2. Sleep Medications Market Forecast and Analysis
7.4.7. Others Market
7.4.7.1. Overview
7.4.7.2. Others Market Forecast and Analysis
8. AUTISM THERAPY MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
8.1. OVERVIEW
8.2. TYPE MARKET FORECASTS AND ANALYSIS
8.3. ASPERGER'S SYNDROME
8.3.1. Overview
8.3.2. Asperger's Syndrome Market Forecast and Analysis
8.4. AUTISTIC DISORDER
8.4.1. Overview
8.4.2. Autistic Disorder Market Forecast and Analysis
8.5. CHILDHOOD DISINTEGRATIVE DISORDER
8.5.1. Overview
8.5.2. Childhood Disintegrative Disorder Market Forecast and Analysis
8.6. PERVASIVE DEVELOPMENTAL DISORDER (PDD)
8.6.1. Overview
8.6.2. Pervasive Developmental Disorder (PDD) Market Forecast and Analysis
9. AUTISM THERAPY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Autism Therapy Market Overview
9.1.2 North America Autism Therapy Market Forecasts and Analysis
9.1.3 North America Autism Therapy Market Forecasts and Analysis - By Therapy
9.1.4 North America Autism Therapy Market Forecasts and Analysis - By Type
9.1.5 North America Autism Therapy Market Forecasts and Analysis - By Countries
9.1.5.1 United States Autism Therapy Market
9.1.5.1.1 United States Autism Therapy Market by Therapy
9.1.5.1.2 United States Autism Therapy Market by Type
9.1.5.2 Canada Autism Therapy Market
9.1.5.2.1 Canada Autism Therapy Market by Therapy
9.1.5.2.2 Canada Autism Therapy Market by Type
9.1.5.3 Mexico Autism Therapy Market
9.1.5.3.1 Mexico Autism Therapy Market by Therapy
9.1.5.3.2 Mexico Autism Therapy Market by Type
9.2. EUROPE
9.2.1 Europe Autism Therapy Market Overview
9.2.2 Europe Autism Therapy Market Forecasts and Analysis
9.2.3 Europe Autism Therapy Market Forecasts and Analysis - By Therapy
9.2.4 Europe Autism Therapy Market Forecasts and Analysis - By Type
9.2.5 Europe Autism Therapy Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Autism Therapy Market
9.2.5.1.1 Germany Autism Therapy Market by Therapy
9.2.5.1.2 Germany Autism Therapy Market by Type
9.2.5.2 France Autism Therapy Market
9.2.5.2.1 France Autism Therapy Market by Therapy
9.2.5.2.2 France Autism Therapy Market by Type
9.2.5.3 Italy Autism Therapy Market
9.2.5.3.1 Italy Autism Therapy Market by Therapy
9.2.5.3.2 Italy Autism Therapy Market by Type
9.2.5.4 Spain Autism Therapy Market
9.2.5.4.1 Spain Autism Therapy Market by Therapy
9.2.5.4.2 Spain Autism Therapy Market by Type
9.2.5.5 United Kingdom Autism Therapy Market
9.2.5.5.1 United Kingdom Autism Therapy Market by Therapy
9.2.5.5.2 United Kingdom Autism Therapy Market by Type
9.2.5.6 Rest of Europe Autism Therapy Market
9.2.5.6.1 Rest of Europe Autism Therapy Market by Therapy
9.2.5.6.2 Rest of Europe Autism Therapy Market by Type
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Autism Therapy Market Overview
9.3.2 Asia-Pacific Autism Therapy Market Forecasts and Analysis
9.3.3 Asia-Pacific Autism Therapy Market Forecasts and Analysis - By Therapy
9.3.4 Asia-Pacific Autism Therapy Market Forecasts and Analysis - By Type
9.3.5 Asia-Pacific Autism Therapy Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Autism Therapy Market
9.3.5.1.1 Australia Autism Therapy Market by Therapy
9.3.5.1.2 Australia Autism Therapy Market by Type
9.3.5.2 China Autism Therapy Market
9.3.5.2.1 China Autism Therapy Market by Therapy
9.3.5.2.2 China Autism Therapy Market by Type
9.3.5.3 India Autism Therapy Market
9.3.5.3.1 India Autism Therapy Market by Therapy
9.3.5.3.2 India Autism Therapy Market by Type
9.3.5.4 Japan Autism Therapy Market
9.3.5.4.1 Japan Autism Therapy Market by Therapy
9.3.5.4.2 Japan Autism Therapy Market by Type
9.3.5.5 South Korea Autism Therapy Market
9.3.5.5.1 South Korea Autism Therapy Market by Therapy
9.3.5.5.2 South Korea Autism Therapy Market by Type
9.3.5.6 Rest of Asia-Pacific Autism Therapy Market
9.3.5.6.1 Rest of Asia-Pacific Autism Therapy Market by Therapy
9.3.5.6.2 Rest of Asia-Pacific Autism Therapy Market by Type
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Autism Therapy Market Overview
9.4.2 Middle East and Africa Autism Therapy Market Forecasts and Analysis
9.4.3 Middle East and Africa Autism Therapy Market Forecasts and Analysis - By Therapy
9.4.4 Middle East and Africa Autism Therapy Market Forecasts and Analysis - By Type
9.4.5 Middle East and Africa Autism Therapy Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Autism Therapy Market
9.4.5.1.1 South Africa Autism Therapy Market by Therapy
9.4.5.1.2 South Africa Autism Therapy Market by Type
9.4.5.2 Saudi Arabia Autism Therapy Market
9.4.5.2.1 Saudi Arabia Autism Therapy Market by Therapy
9.4.5.2.2 Saudi Arabia Autism Therapy Market by Type
9.4.5.3 U.A.E Autism Therapy Market
9.4.5.3.1 U.A.E Autism Therapy Market by Therapy
9.4.5.3.2 U.A.E Autism Therapy Market by Type
9.4.5.4 Rest of Middle East and Africa Autism Therapy Market
9.4.5.4.1 Rest of Middle East and Africa Autism Therapy Market by Therapy
9.4.5.4.2 Rest of Middle East and Africa Autism Therapy Market by Type
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Autism Therapy Market Overview
9.5.2 South and Central America Autism Therapy Market Forecasts and Analysis
9.5.3 South and Central America Autism Therapy Market Forecasts and Analysis - By Therapy
9.5.4 South and Central America Autism Therapy Market Forecasts and Analysis - By Type
9.5.5 South and Central America Autism Therapy Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Autism Therapy Market
9.5.5.1.1 Brazil Autism Therapy Market by Therapy
9.5.5.1.2 Brazil Autism Therapy Market by Type
9.5.5.2 Argentina Autism Therapy Market
9.5.5.2.1 Argentina Autism Therapy Market by Therapy
9.5.5.2.2 Argentina Autism Therapy Market by Type
9.5.5.3 Rest of South and Central America Autism Therapy Market
9.5.5.3.1 Rest of South and Central America Autism Therapy Market by Therapy
9.5.5.3.2 Rest of South and Central America Autism Therapy Market by Type
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL AUTISM THERAPY MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. AUTISM THERAPY MARKET, KEY COMPANY PROFILES
12.1. ABBVIE INC. (ALLERGAN)
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PFIZER, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. JOHNSON AND JOHNSON SERVICES, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ASTRAZENECA PLC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. Q BIOMED INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. AUTISM SPEAKS INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. TRUMPET BEHAVIORAL HEALTH
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. FUSION AUTISM CENTER
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. HOPEBRIDGE AUTISM THERAPY CENTER
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. OTSUKA AMERICA PHARMACEUTICAL, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. AbbVie Inc. (Allergan)
2. Pfizer, Inc.
3. Johnson and Johnson Services, Inc.
4. AstraZeneca plc
5. Q BioMed Inc.
6. Autism Speaks Inc.
7. Trumpet Behavioral Health
8. Fusion Autism Center
9. Hopebridge Autism Therapy Center
10. Otsuka America Pharmaceutical, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.